| Pharmaceutical active ingredients: |
| Ethinyl EstradiolLynestrenol |
| Available forms, composition and doses of Nuriphasic: |
| Tablets; Oral; Ethinyl Estradiol; Lynestrenol |
| Nuriphasic medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA03 - Lynestrenol and estrogenG03AB02 - Lynestrenol and estrogenG03CA01 - EthinylestradiolG03FA07 - Lynestrenol and estrogenG03FB02 - Lynestrenol and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Organon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Minilyn | Ethinyl Estradiol; Lynestrenol | Organon |
| Ministat | Ethinyl Estradiol; Lynestrenol | Organon |
| Neo Lyndiol | Ethinyl Estradiol; Lynestrenol | Organon |
| Noracyclin | Ethinyl Estradiol; Lynestrenol | Novartis |
| Normophasic | Ethinyl Estradiol; Lynestrenol | Orion Pharma |
| Ovamezzo | Ethinyl Estradiol; Lynestrenol | CCD Laboratoires |
| Ovanon | Ethinyl Estradiol; Lynestrenol | Organon; Nourypharma; Orion Pharma |
| Ovariostat | Ethinyl Estradiol; Lynestrenol | Organon |
| Ovoresta | Ethinyl Estradiol; Lynestrenol | Organon; Akzo Nobel |
| Ovoresta M | Ethinyl Estradiol; Lynestrenol | Organon |